Recovery & Repair

PTH(1-34)

Parathyroid Hormone Fragment 1-34 (Teriparatide)

The biologically active N-terminal fragment of parathyroid hormone, teriparatide (Forteo) is the only FDA-approved anabolic agent for osteoporosis. It stimulates new bone formation rather than merely preventing bone loss.

Bone DensityOsteoporosisAnabolicFracture Healing

Quick Reference

Category
Recovery & Repair
Research Claims
3 reviewed
Explore Research

Mechanism of Action

Intermittent PTH(1-34) administration activates PTH1R receptors on osteoblasts, stimulating bone formation through Wnt signaling and IGF-1 upregulation. Unlike continuous PTH (which is catabolic), pulsatile dosing produces a net anabolic effect, increasing bone mineral density and reducing fracture risk.

Health Claims & Evidence

Increases bone mineral density in osteoporosis

StrongFDA-approved; multiple RCTs show 8–13% BMD increase over 18–24 months

Reduces vertebral and non-vertebral fracture risk

Strongpivotal trial showed 65% reduction in vertebral fractures

Accelerates fracture healing

Moderatecase series and small trials show faster fracture union

Short-Term Effects

Increased bone formation markers within 1–3 months.

Long-Term Effects

Significant BMD increase over 18–24 months; benefits persist after discontinuation if followed by antiresorptive therapy.

Side Effects

Nausea, leg cramps, dizziness, hypercalcemia. Black box warning for osteosarcoma risk (animal data).

Contraindications

Prior radiation therapy to skeleton, Paget's disease, unexplained alkaline phosphatase elevation, pediatric patients, pregnancy.

This profile is provided for educational research only. It is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Verify primary sources and consult a qualified healthcare professional for medical decisions.

Research Papers

Teriparatide and vertebral fracture risk

Neer et al. · New England Journal of Medicine · 2001

Educational research only. This profile is not a treatment recommendation or dosing guide. Human evidence, safety information and regulatory status vary by substance. Consult a qualified healthcare professional for medical decisions.

Related Peptides

Explore the research further

Our AI Research Advisor can help you explore the evidence on PTH(1-34) and related peptides, and prepare an educational research summary.

Explore Research